310 related articles for article (PubMed ID: 33358704)
21. Seasonal vaccination with RTS,S/AS01
Dicko A; Ouedraogo JB; Zongo I; Sagara I; Cairns M; Yerbanga RS; Issiaka D; Zoungrana C; Sidibe Y; Tapily A; Nikièma F; Sompougdou F; Sanogo K; Kaya M; Yalcouye H; Dicko OM; Diarra M; Diarra K; Thera I; Haro A; Sienou AA; Traore S; Mahamar A; Dolo A; Kuepfer I; Snell P; Grant J; Webster J; Milligan P; Lee C; Ockenhouse C; Ofori-Anyinam O; Tinto H; Djimde A; Chandramohan D; Greenwood B
Lancet Infect Dis; 2024 Jan; 24(1):75-86. PubMed ID: 37625434
[TBL] [Abstract][Full Text] [Related]
22. Seven-year kinetics of RTS, S/AS01-induced anti-CSP antibodies in young Kenyan children.
Mugo RM; Mwai K; Mwacharo J; Shee FM; Musyoki JN; Wambua J; Otieno E; Bejon P; Ndungu FM
Malar J; 2021 Dec; 20(1):452. PubMed ID: 34856981
[TBL] [Abstract][Full Text] [Related]
23. Induction, decay, and determinants of functional antibodies following vaccination with the RTS,S malaria vaccine in young children.
Feng G; Kurtovic L; Agius PA; Aitken EH; Sacarlal J; Wines BD; Hogarth PM; Rogerson SJ; Fowkes FJI; Dobaño C; Beeson JG
BMC Med; 2022 Aug; 20(1):289. PubMed ID: 36002841
[TBL] [Abstract][Full Text] [Related]
24. Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children.
Olotu A; Clement F; Jongert E; Vekemans J; Njuguna P; Ndungu FM; Marsh K; Leroux-Roels G; Bejon P
PLoS One; 2014; 9(12):e115126. PubMed ID: 25506706
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional correlates of malaria in RTS,S/AS01-vaccinated African children: a matched case-control study.
Moncunill G; Carnes J; Chad Young W; Carpp L; De Rosa S; Campo JJ; Nhabomba A; Mpina M; Jairoce C; Finak G; Haas P; Muriel C; Van P; Sanz H; Dutta S; Mordmüller B; Agnandji ST; Díez-Padrisa N; Williams NA; Aponte JJ; Valim C; Neafsey DE; Daubenberger C; McElrath MJ; Dobaño C; Stuart K; Gottardo R
Elife; 2022 Jan; 11():. PubMed ID: 35060479
[TBL] [Abstract][Full Text] [Related]
26. A phase IIA extension study evaluating the effect of booster vaccination with a fractional dose of RTS,S/AS01
Moon JE; Greenleaf ME; Regules JA; Debois M; Duncan EH; Sedegah M; Chuang I; Lee CK; Sikaffy AK; Garver LS; Ivinson K; Angov E; Morelle D; Lievens M; Ockenhouse CF; Ngauy V; Ofori-Anyinam O;
Vaccine; 2021 Oct; 39(43):6398-6406. PubMed ID: 34593270
[TBL] [Abstract][Full Text] [Related]
27. A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E.
Ndungu FM; Mwacharo J; Kimani D; Kai O; Moris P; Jongert E; Vekemans J; Olotu A; Bejon P
PLoS One; 2012; 7(12):e52870. PubMed ID: 23300801
[TBL] [Abstract][Full Text] [Related]
28. RTS,S/AS01E Malaria Vaccine Induces Memory and Polyfunctional T Cell Responses in a Pediatric African Phase III Trial.
Moncunill G; De Rosa SC; Ayestaran A; Nhabomba AJ; Mpina M; Cohen KW; Jairoce C; Rutishauser T; Campo JJ; Harezlak J; Sanz H; Díez-Padrisa N; Williams NA; Morris D; Aponte JJ; Valim C; Daubenberger C; Dobaño C; McElrath MJ
Front Immunol; 2017; 8():1008. PubMed ID: 28878775
[TBL] [Abstract][Full Text] [Related]
29. A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive Adults.
Moon JE; Ockenhouse C; Regules JA; Vekemans J; Lee C; Chuang I; Traskine M; Jongert E; Ivinson K; Morelle D; Komisar JL; Lievens M; Sedegah M; Garver LS; Sikaffy AK; Waters NC; Ballou WR; Ofori-Anyinam O;
J Infect Dis; 2020 Oct; 222(10):1681-1691. PubMed ID: 32687161
[TBL] [Abstract][Full Text] [Related]
30. Duration of vaccine efficacy against malaria: 5th year of follow-up in children vaccinated with RTS,S/AS02 in Mozambique.
Campo JJ; Sacarlal J; Aponte JJ; Aide P; Nhabomba AJ; Dobaño C; Alonso PL
Vaccine; 2014 Apr; 32(19):2209-16. PubMed ID: 24631081
[TBL] [Abstract][Full Text] [Related]
31. Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.
Olotu A; Fegan G; Wambua J; Nyangweso G; Awuondo KO; Leach A; Lievens M; Leboulleux D; Njuguna P; Peshu N; Marsh K; Bejon P
N Engl J Med; 2013 Mar; 368(12):1111-20. PubMed ID: 23514288
[TBL] [Abstract][Full Text] [Related]
32. Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection.
Kester KE; Cummings JF; Ofori-Anyinam O; Ockenhouse CF; Krzych U; Moris P; Schwenk R; Nielsen RA; Debebe Z; Pinelis E; Juompan L; Williams J; Dowler M; Stewart VA; Wirtz RA; Dubois MC; Lievens M; Cohen J; Ballou WR; Heppner DG;
J Infect Dis; 2009 Aug; 200(3):337-46. PubMed ID: 19569965
[TBL] [Abstract][Full Text] [Related]
33. Antibody responses to the RTS,S/AS01
Sanchez L; Vidal M; Jairoce C; Aguilar R; Ubillos I; Cuamba I; Nhabomba AJ; Williams NA; Díez-Padrisa N; Cavanagh D; Angov E; Coppel RL; Gaur D; Beeson JG; Dutta S; Aide P; Campo JJ; Moncunill G; Dobaño C
NPJ Vaccines; 2020; 5():46. PubMed ID: 32550014
[TBL] [Abstract][Full Text] [Related]
34. Multifunctional Antibodies Are Induced by the RTS,S Malaria Vaccine and Associated With Protection in a Phase 1/2a Trial.
Kurtovic L; Atre T; Feng G; Wines BD; Chan JA; Boyle MJ; Drew DR; Hogarth PM; Fowkes FJI; Bergmann-Leitner ES; Beeson JG
J Infect Dis; 2021 Oct; 224(7):1128-1138. PubMed ID: 32236404
[TBL] [Abstract][Full Text] [Related]
35. Assessing the safety, impact and effectiveness of RTS,S/AS01
Praet N; Asante KP; Bozonnat MC; Akité EJ; Ansah PO; Baril L; Boahen O; Mendoza YG; Haine V; Kariuki S; Lamy M; Maleta K; Mungwira R; Ndeketa L; Oduro A; Ogutu B; Olewe F; Oneko M; Orsini M; Roman F; Bahmanyar ER; Rosillon D; Schuerman L; Sing'oei V; Terlouw DJ; Wéry S; Otieno W; Pirçon JY
Malar J; 2022 Apr; 21(1):132. PubMed ID: 35468801
[TBL] [Abstract][Full Text] [Related]
36. Impact of the RTS,S malaria vaccine candidate on naturally acquired antibody responses to multiple asexual blood stage antigens.
Campo JJ; Dobaño C; Sacarlal J; Guinovart C; Mayor A; Angov E; Dutta S; Chitnis C; Macete E; Aponte JJ; Alonso PL
PLoS One; 2011; 6(10):e25779. PubMed ID: 22022448
[TBL] [Abstract][Full Text] [Related]
37. Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A.
Walsh DS; Gettayacamin M; Leitner WW; Lyon JA; Stewart VA; Marit G; Pichyangkul S; Gosi P; Tongtawe P; Kester KE; Holland CA; Kolodny N; Cohen J; Voss G; Ballou WR; Heppner DG
Vaccine; 2006 May; 24(19):4167-78. PubMed ID: 16574282
[TBL] [Abstract][Full Text] [Related]
38. Induction of Plasmodium falciparum-specific CD4+ T cells and memory B cells in Gabonese children vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D).
Agnandji ST; Fendel R; Mestré M; Janssens M; Vekemans J; Held J; Gnansounou F; Haertle S; von Glasenapp I; Oyakhirome S; Mewono L; Moris P; Lievens M; Demoitie MA; Dubois PM; Villafana T; Jongert E; Olivier A; Cohen J; Esen M; Kremsner PG; Lell B; Mordmüller B
PLoS One; 2011 Apr; 6(4):e18559. PubMed ID: 21494604
[TBL] [Abstract][Full Text] [Related]
39. RTS,S vaccination is associated with serologic evidence of decreased exposure to Plasmodium falciparum liver- and blood-stage parasites.
Campo JJ; Aponte JJ; Skinner J; Nakajima R; Molina DM; Liang L; Sacarlal J; Alonso PL; Crompton PD; Felgner PL; Dobaño C
Mol Cell Proteomics; 2015 Mar; 14(3):519-31. PubMed ID: 25547414
[TBL] [Abstract][Full Text] [Related]
40. Antigen-stimulated PBMC transcriptional protective signatures for malaria immunization.
Moncunill G; Scholzen A; Mpina M; Nhabomba A; Hounkpatin AB; Osaba L; Valls R; Campo JJ; Sanz H; Jairoce C; Williams NA; Pasini EM; Arteta D; Maynou J; Palacios L; Duran-Frigola M; Aponte JJ; Kocken CHM; Agnandji ST; Mas JM; Mordmüller B; Daubenberger C; Sauerwein R; Dobaño C
Sci Transl Med; 2020 May; 12(543):. PubMed ID: 32404508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
